ENSC
Ensysce Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.41
-0.02 ▼ -6.22%
🌙 3월 13일 7:54 PM ET (한국 3/14 08:54)
$0.40
+0.00 -0.86%
| Index | - | P/E | - | EPS (ttm) | -6.1 | Insider Own | 0.28% | Shs Outstand | 0.00B | Perf Week | -25.61% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 93.87% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -0.49% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -1.26 | Inst Own | 13.84% | Short Float | 9.02% | Perf Quarter | -74.24% |
| Income | -0.01B | P/S | 0.33 | EPS this Y | 58.69% | Inst Trans | 3.99% | Short Ratio | 0.05 | Perf Half Y | -80.89% |
| Sales | 0.00B | P/B | 1.08 | EPS next 5Y | - | ROA | -174.66% | Short Interest | 0.33M | Perf YTD | -55.76% |
| Book/sh | 0.38 | P/C | 0.89 | EPS past 3/5Y | 87.1% - | ROE | -270.54% | 52W High | -91.61% ($4.85) | Perf Year | -89.57% |
| Cash/sh | 0.46 | P/FCF | - | Sales past 3/5Y | 13.84% - | ROIC | -911.82% | 52W Low | 29.45% ($0.31) | Perf 3Y | -99.6% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 77.64% | Gross Margin | - | Volatility(W/M) | 10.42% 20.23% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | -0.04 | Sales Y/Y TTM | 1.51% | Oper. Margin | -245.89% | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.27 | EPS Q/Q | -228.75% | Profit Margin | -244.49% | RSI (14) | 37.29 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.27 | Sales Q/Q | -85.58% | SMA20 | -12.16% ($0.47) | Beta | 1.21 | Target Price | $16.45 |
| Payout | - | Debt/Eq | 0.3 | Earnings | 2025/11/17 | SMA50 | -38.48% ($0.67) | Rel Volume | 0.05 | Prev Close | $0.43 |
| Employees | 9 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -75.99% ($1.71) | Avg Volume(3M) | 6.03M | Price | $0.41 |
| IPO | 2018/2/26 | Option/Short | No/Yes | Trades | 467 | Volume | 289,657 | Change | -6.22% |
뉴스 로딩 중...